Latest Insider Transactions at Angiodynamics Inc (ANGO)
This section provides a real-time view of insider transactions for Angiodynamics Inc (ANGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANGIODYNAMICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANGIODYNAMICS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 21
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.43%
|
$3,160
$8.99 P/Share
|
Jul 21
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.39%
|
$2,216
$8.99 P/Share
|
Jul 21
2025
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
667
-0.26%
|
$5,336
$8.99 P/Share
|
Jul 20
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.39%
|
$2,872
$8.69 P/Share
|
Jul 20
2025
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,655
-0.38%
|
$53,240
$8.84 P/Share
|
Jul 20
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-0.36%
|
$2,008
$8.69 P/Share
|
Jul 20
2025
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-0.91%
|
$4,928
$8.69 P/Share
|
Jul 20
2025
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.28%
|
$5,736
$8.69 P/Share
|
Jul 19
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.09%
|
$8,200
$8.69 P/Share
|
Jul 19
2025
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,651
-0.49%
|
$69,208
$8.69 P/Share
|
Jul 19
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-1.03%
|
$5,880
$8.69 P/Share
|
Jul 19
2025
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-2.86%
|
$15,864
$8.69 P/Share
|
Jul 19
2025
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,585
-1.0%
|
$20,680
$8.69 P/Share
|
Jul 17
2025
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
3,074
-4.24%
|
$24,592
$8.74 P/Share
|
Jul 16
2025
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+10.96%
|
-
|
Jul 16
2025
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+16.35%
|
-
|
Jul 16
2025
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+14.4%
|
-
|
Jul 16
2025
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+17.49%
|
-
|
Jul 16
2025
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+14.44%
|
-
|
Jul 16
2025
|
Lorinda Burgess |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+24.23%
|
-
|
Jul 16
2025
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
32,423
+30.92%
|
-
|
Jul 16
2025
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
17,675
+9.57%
|
-
|
Jul 16
2025
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
26,268
+21.83%
|
-
|
Jul 16
2025
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
86,997
+25.09%
|
-
|
Jul 16
2025
|
Lawrence T Weiss SVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,900
+26.99%
|
-
|
Jul 16
2025
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
206,253
+18.85%
|
-
|
Jul 16
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
29,349
+29.2%
|
-
|
Jan 16
2025
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Open market or private sale
|
Direct |
4,060
-8.85%
|
$48,720
$12.31 P/Share
|
Dec 02
2024
|
Lawrence T Weiss SVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,697
+50.0%
|
-
|
Oct 10
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Open market or private purchase
|
Direct |
100
+0.22%
|
$600
$6.08 P/Share
|
Oct 08
2024
|
Stephen A Trowbridge EVP and CFO |
BUY
Open market or private purchase
|
Direct |
1,700
+0.97%
|
$8,500
$5.86 P/Share
|
Oct 07
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Open market or private purchase
|
Direct |
768
+1.65%
|
$4,608
$6.09 P/Share
|
Oct 07
2024
|
James C Clemmer President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+2.85%
|
$120,000
$6.03 P/Share
|
Jul 21
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
667
-0.4%
|
$4,669
$7.13 P/Share
|
Jul 21
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.67%
|
$1,939
$7.13 P/Share
|
Jul 21
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,372
-0.53%
|
$23,604
$7.13 P/Share
|
Jul 21
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-1.07%
|
$2,891
$7.13 P/Share
|
Jul 21
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.62%
|
$2,765
$7.13 P/Share
|
Jul 20
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.43%
|
$5,019
$7.13 P/Share
|
Jul 20
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-0.6%
|
$1,757
$7.13 P/Share
|
Jul 20
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,982
-0.47%
|
$20,874
$7.13 P/Share
|
Jul 20
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.58%
|
$4,312
$7.13 P/Share
|
Jul 20
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.56%
|
$2,513
$7.13 P/Share
|
Jul 19
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,585
-1.49%
|
$18,095
$7.18 P/Share
|
Jul 19
2024
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,817
+0.59%
|
-
|
Jul 19
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.57%
|
$7,175
$7.18 P/Share
|
Jul 19
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,307
-1.29%
|
$58,149
$7.18 P/Share
|
Jul 19
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-1.74%
|
$5,145
$7.18 P/Share
|
Jul 19
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-4.83%
|
$13,881
$7.18 P/Share
|
Jul 17
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
2,485
-5.85%
|
$17,395
$7.4 P/Share
|